Day One Biopharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DAWN, updated each market day.
DAWN AI Sentiment
AI sees no strong directional signal for Day One Biopharmaceuticals, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Day One Biopharmaceuticals, Inc. Common Stock
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
Sector
Exchange
Market Cap
$2,218,834,402
Cap Tier
Employees
178
Headquarters
BRISBANE, CA
Listed Since
May 27, 2021
Website
DAWN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DAWN Volatility
Day One Biopharmaceuticals, Inc. Common Stock has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
